On a planet with 7,600 million people, it has made it clear that humans are related to the human species in relation to the sick. With all the technological advances that we have achieved in the last decades, a virus paralyzes our daily life and transforms our way of life. The actual situation we have recorded, one more time, that individual and collective health is one of the great retreats of humanity, a great opportunity to innovate and develop distinct solutions that allow us to generate a valuable and sustainable change.
Introducing the disciplines of distinct disciplines such as genomics, pharmacology and nutrition with the technological advances that will allow the hyperpersonalization of medicine, bringing health to a new level that will allow us to make global futures as one. Now, thanks to the Artificial Intelligence and the Internet of Things, we will finally find out the reality of our dedication.
Recently, medicine has been based on generic treatments, usually reactive, to counteract problems that arise in our health and increase our quality of life. However, we find in the umbrella of a world of hyperpersonalized medicine where, through the study of our DNA, we can know the probability of having specific diseases, how we will treat, how we will treat them, what we do the most adequate for us.
If it is said that, in the complete DNA of the organisms, known as the genome, it is located in the “Manual for construction and maintenance” which, interpreting it, can increase the individual’s hope and quality of life as we increase it. bienestar de la specie en general. Applying humanitarian aid to reduce the origins of public health problems has now become a huge issue as cancer or psychiatric disorders.
If it initially takes more than a decade and is around 300 million dollars, it describes the complete sequence of the human genome, now it can take up to 48 hours per fraction of the cost: less than a thousand dollars. Little by little, we will democratize the use of these new advances to transform our life.
The need for a hyperpersonalized medicine to help treat cancer before it manifests itself, to find out the origin of mental health problems in time for controllers and recommend effective treatment and nutritional plans for the characteristics. In addition, it can help combat rare diseases, which are associated with less than 200,000 people diagnosed, considering that 80% of them have genetic causes.
One of the applications of this new trend in medicine is the pharmacogenomics, which consists in the study and application of genetic information to receive the most effective medicine in the adequate dose according to the composition of each individual, to agree with the definition leader of the Laboratory of Pharmacogenomics of the Instituto Nacional de Medicina Genómica de México (INMEGEN). In this way, it is possible to avoid receiving drugs that do not have serious efficiencies or to have significant secondary effects for the individuals.
Advances in these trends signal the addition of a new era characterized by precision medicine, in order to obtain better results for patients at a time when risk situations are minimized. Do you imagine it different that a pandemic would take place in a world where the risk factors of each individual are known? It is necessary to make a series of strategic decisions on the part of the governesses and the companies as long as the processes of development are agilized.
In the same way, it is hoped that the integration of genetics with medicine can help to reduce inequality: launch a universal health system giving results that do not depend on the acquisition capacity of individuals, one of the major retreats of economies en desarrollo como la mexicana. However, as all technological advances, it depends on what medium we decide to use as a species. Tenemos frente a nosotros has the potential to launch a utopia in health matter or to distort it into a dystopia worthy of a science fiction movie.
The pandemic that we live records the importance of maintenance and sufficient resources in the health sector and its workers, is currently concentrating our efforts on continuing to innovate and develop solutions that allow us to launch more futures for all.
In Mexico, we have significant advances in genomic studies, and it is inevitable to prioritize its development as a measure of great value aggregated for the future of the quality of life of Mexicans.